These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 16476116)
41. Evaluation of limited sampling strategies for tacrolimus. Op den Buijsch RA; van de Plas A; Stolk LM; Christiaans MH; van Hooff JP; Undre NA; van Dieijen-Visser MP; Bekers O Eur J Clin Pharmacol; 2007 Nov; 63(11):1039-44. PubMed ID: 17712551 [TBL] [Abstract][Full Text] [Related]
42. Effect of hematocrit on pharmacokinetics of tacrolimus in adult living donor liver transplant recipients. Minematsu T; Sugiyama E; Kusama M; Hori S; Yamada Y; Ohtani H; Sawada Y; Sato H; Takayama T; Sugawara Y; Makuuchi M; Iga T Transplant Proc; 2004 Jun; 36(5):1506-11. PubMed ID: 15251372 [TBL] [Abstract][Full Text] [Related]
43. Effect of CYP3A5 genotype on renal allograft recipients treated with tacrolimus. Chen JS; Li LS; Cheng DR; Ji SM; Sun QQ; Cheng Z; Wen JQ; Sha GZ; Liu ZH Transplant Proc; 2009 Jun; 41(5):1557-61. PubMed ID: 19545678 [TBL] [Abstract][Full Text] [Related]
44. Target range maximum of cyclosporine blood concentration two hours post dose in stable liver transplant patients. Li J; Dahmen U; Beckebaum S; Cicinnati V; Valentin-Gamazo C; Frilling A; Malago M; Broelsch CE Eur J Med Res; 2006 Apr; 11(4):139-45. PubMed ID: 16720277 [TBL] [Abstract][Full Text] [Related]
45. Pharmacokinetics of enteric-coated mycophenolate sodium in stable liver transplant recipients. Perry TW; Christians U; Trotter JF; Bendrick-Peart J Clin Transplant; 2007; 21(3):413-6. PubMed ID: 17488394 [TBL] [Abstract][Full Text] [Related]
46. Change in oral absorption of tacrolimus in a liver transplant recipient after reversal of jejunoileal bypass: case report. Kelley M; Jain A; Kashyap R; Orloff M; Abt P; Wrobble K; Venkataramanan R; Bozorgzadeh A Transplant Proc; 2005 Sep; 37(7):3165-7. PubMed ID: 16213338 [TBL] [Abstract][Full Text] [Related]
48. Fludrocortisone is effective in the management of tacrolimus-induced hyperkalemia in liver transplant recipients. Dick TB; Raines AA; Stinson JB; Collingridge DS; Harmston GE Transplant Proc; 2011 Sep; 43(7):2664-8. PubMed ID: 21911143 [TBL] [Abstract][Full Text] [Related]
49. Severe elevations of FK506 blood concentration due to diarrhea in renal transplant recipients. Sato K; Amada N; Sato T; Miura S; Ohashi Y; Sekiguchi S; Satomi S; Okazaki H Clin Transplant; 2004 Oct; 18(5):585-90. PubMed ID: 15344965 [TBL] [Abstract][Full Text] [Related]
50. Bayesian forecasting and prediction of tacrolimus concentrations in pediatric liver and adult renal transplant recipients. Willis C; Staatz CE; Tett SE Ther Drug Monit; 2003 Apr; 25(2):158-66. PubMed ID: 12657909 [TBL] [Abstract][Full Text] [Related]
51. Clinical Efficacy and Safety of Tacrolimus in Pakistani Living Donor Liver Transplant Recipients. Azam F; Khan M; Bhatti ABH; Dar FS; Ahmad A; Javed N J Coll Physicians Surg Pak; 2019 Nov; 29(11):1048-1052. PubMed ID: 31659960 [TBL] [Abstract][Full Text] [Related]
52. [Blood concentrations and side effects of tacrolimus in a living renal transplantation]. Ishikawa M; Abo K; Nanba A; Satoh S; Mikawa Y; Higashi T; Nakamura K; Miyazaki M Masui; 2001 Mar; 50(3):246-50. PubMed ID: 11296433 [TBL] [Abstract][Full Text] [Related]
53. Severe symptomatic hyponatremia--an uncommon presentation of tacrolimus nephrotoxicity. Bagchi S; Husain Zaidi S; Prasad Mathur R Nephrol Dial Transplant; 2011 Jun; 26(6):2042-4. PubMed ID: 21454354 [TBL] [Abstract][Full Text] [Related]
54. Tacrolimus Concentrations Measured in Excreted Bile in Liver Transplant Recipients: The STABILE Study. Rayar M; Tron C; Locher C; Chebaro A; Beaurepaire JM; Blondeau M; Cusumano C; Bardou-Jacquet E; Houssel-Debry P; Camus C; Petitcollin A; Verdier MC; Lakéhal M; Desfourneaux V; Sulpice L; Meunier B; Bellissant E; Boudjema K; Lemaitre F Clin Ther; 2018 Dec; 40(12):2088-2098. PubMed ID: 30467013 [TBL] [Abstract][Full Text] [Related]
55. An abbreviated area-under-the-curve monitoring for tacrolimus in patients with liver transplants. Ku YM; Min DI Ther Drug Monit; 1998 Apr; 20(2):219-23. PubMed ID: 9558138 [TBL] [Abstract][Full Text] [Related]
56. Weight-based tacrolimus trough concentrations post liver transplant. Liu Z; Cheng J; Powell E; Macdonald G; Fawcett J; Lynch S; Martin J Intern Med J; 2019 Jan; 49(1):79-83. PubMed ID: 30043532 [TBL] [Abstract][Full Text] [Related]
57. Factors affecting variability in distribution of tacrolimus in liver transplant recipients. Zahir H; McCaughan G; Gleeson M; Nand RA; McLachlan AJ Br J Clin Pharmacol; 2004 Mar; 57(3):298-309. PubMed ID: 14998426 [TBL] [Abstract][Full Text] [Related]
58. Tacrolimus intrapatient variability in solid organ transplantation: A multiorgan perspective. Schumacher L; Leino AD; Park JM Pharmacotherapy; 2021 Jan; 41(1):103-118. PubMed ID: 33131078 [TBL] [Abstract][Full Text] [Related]
59. Treatment of acute tacrolimus whole-blood elevation with phenobarbital in the pediatric liver transplant recipient. Quirós-Tejeira RE; Chang IF; Bristow LJ; Karpen SJ; Goss JA Pediatr Transplant; 2005 Dec; 9(6):792-6. PubMed ID: 16269053 [TBL] [Abstract][Full Text] [Related]
60. Cassia angustifolia and tacrolimus interaction in a liver transplant patient, a case report. Beltrá-Picó I; Díaz-González M; Nalda-Molina R; Ramon-Lopez A; Pascual-Bartolomé S; Miralles-Macià CF; Rodríguez-Soler M; Más-Serrano P Br J Clin Pharmacol; 2024 Jul; 90(7):1745-1750. PubMed ID: 38657592 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]